找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Immunotherapy; Methods and Protocol Velia Siciliano,Francesca Ceroni Book 2024 The Editor(s) (if applicable) and The Author(s), unde

[復(fù)制鏈接]
樓主: 使醉
41#
發(fā)表于 2025-3-28 17:43:11 | 只看該作者
Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell Lenetically modified TILs. The protocol includes instructions for retroviral transduction and mRNA transfection of circulating T cells or T-cell lines. The GOIs most commonly introduced into the target cells are chimeric antigen receptors (CARs); genetic adjuvants, such as membrane-bound interleukins; and antitumor T-cell receptors (TCRs).
42#
發(fā)表于 2025-3-28 21:43:53 | 只看該作者
43#
發(fā)表于 2025-3-29 00:32:13 | 只看該作者
44#
發(fā)表于 2025-3-29 05:13:06 | 只看該作者
https://doi.org/10.1007/978-981-10-3193-9resent chapter, we provide a protocol to identify and characterize the time evolution of apoptosis by time-lapse fluorescence and confocal imaging in a 3D microfluidic coculture murine model including cancer and spleen cells.
45#
發(fā)表于 2025-3-29 10:39:33 | 只看該作者
46#
發(fā)表于 2025-3-29 12:39:52 | 只看該作者
47#
發(fā)表于 2025-3-29 17:19:31 | 只看該作者
https://doi.org/10.1007/978-981-10-3193-9argets for their capacity to infiltrate and eliminate human solid tumors in vivo. Here, we provide a detailed protocol to evaluate human CAR CD4. helper T cells and CD8. cytotoxic T cells in immunodeficient (NSG) mice bearing antigen-expressing human solid tumors.
48#
發(fā)表于 2025-3-29 19:56:57 | 只看該作者
https://doi.org/10.1007/978-981-10-3193-9 . transposon system via electroporation and to further expand these engineered CAR-NK cells in a large scale together with artificial antigen-presenting feeder cells. This method can stably engineer human primary NK cells with high efficiency and supply sufficient scale of engineered CAR-NK cells for the future possible clinical applications.
49#
發(fā)表于 2025-3-30 00:51:52 | 只看該作者
50#
發(fā)表于 2025-3-30 05:26:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-30 04:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
延庆县| 武川县| 从江县| 合川市| 海原县| 昭平县| 合阳县| 明星| 名山县| 孟津县| 舞钢市| 且末县| 九龙城区| 丽水市| 莫力| 汾西县| 沾化县| 霞浦县| 兴隆县| 博野县| 昌平区| 平果县| 新绛县| 吴堡县| 崇阳县| 象州县| 高雄市| 东莞市| 东乡族自治县| 枣阳市| 梁平县| 台江县| 阳山县| 公安县| 宜州市| 隆回县| 双桥区| 独山县| 班玛县| 汉中市| 英吉沙县|